OIMU
REGN icon

Osmosis Investment Management UK’s Regeneron Pharmaceuticals REGN Stock Holding History

Osmosis Investment Management UK’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
2,817
-3,102
-52% -$2.11M 0.08% 203
2026
Q1 		$4.57M Sell
5,919
-113
-2% -$86.5K 0.12% 159
2025
Q4 		$4.66M Buy
+6,032
New +$4.1M 0.12% 169

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Osmosis Investment Management UK's REGN Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Regeneron Pharmaceuticals (REGN) stake by 52% in Q2 2026, selling an estimated $2.11M and leaving 2,817 shares worth $1.76M. The position accounts for 0.08% of the portfolio, ranked #203.

Osmosis Investment Management UK first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.66M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Osmosis Investment Management UK held 2,817 shares of Regeneron Pharmaceuticals worth $1.76M as of Q2 2026.
  • Osmosis Investment Management UK sold 3,102 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.11M.
  • Regeneron Pharmaceuticals made up 0.08% of Osmosis Investment Management UK's portfolio in Q2 2026, its #203 holding.
  • Osmosis Investment Management UK first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Regeneron Pharmaceuticals position peaked at $4.66M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.